
Results
6
6 companies
Ascelia Pharma
Market Cap: SEK 346.4m
A biotech company, develops identifies, develops, and commercializes novel drugs to treat orphan oncology treatments in Sweden.
ACE
SEK 2.73
7D
-8.5%
1Y
-3.4%
Camurus
Market Cap: SEK 27.6b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
CAMX
SEK 461.40
7D
2.8%
1Y
-19.0%
Devyser Diagnostics
Market Cap: SEK 1.3b
Engages in the development, manufacture, and sale of diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.
DVYSR
SEK 76.40
7D
-1.8%
1Y
-25.1%
Bonesupport Holding
Market Cap: SEK 12.5b
An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.
BONEX
SEK 187.50
7D
5.0%
1Y
-36.2%
Guard Therapeutics International
Market Cap: SEK 30.2m
A clinical-stage biotechnology company, identifies and develops medicines to treat kidney diseases in Sweden.
GUARD
SEK 1.50
7D
9.9%
1Y
-90.2%
IDL Diagnostics
Market Cap: SEK 64.0m
A vitro diagnostics company, manufactures and sells IVD tests for oncological and bacterial diseases in Sweden.
IDLDX
SEK 0.28
7D
-12.6%
1Y
-50.8%